NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY · Published 2026-07-27 · DOI 10.1007/s00210-026-05645-7
Mingyuan Wu, Fenggang Hou, Zhaoshuo Yang, Zhenfeng Zhu, Yao Wang, Hong Wang
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Wu, M., Hou, F., Yang, Z., et al. (2026). Cycloastragenol overcomes trastuzumab resistance in HER2-positive breast cancer by regulating cell cycle and epithelial-mesenchymal transition through EZH2/PTEN/AKT pathway. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. https://doi.org/10.1007/s00210-026-05645-7